VAERS reports by lot

Moderna COVID-19 lot AR9236B: VAERS reports

184 VAERS reports list lot AR9236B as a Moderna COVID-19 vaccine, received between 2022-08-22 and 2023-09-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
184
Reports
2%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4219%
Respiratory3717%
Gastrointestinal3415%
Cardiac / Cardiovascular2913%
Neurological219%
Dermatological (non-injection-site)199%
Allergic / Anaphylactic115%
Injection-site / Local reaction104%
Thrombotic / Hematological73%
Psychiatric / Neuropsychiatric63%
Musculoskeletal52%
Autoimmune / Immune-mediated21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California34
New York22
New Jersey10
Massachusetts9
Washington9
Pennsylvania7
Texas5
Maryland4
Colorado4
West Virginia4
New Hampshire3
Connecticut3

Reports by month received

2022-085
2022-0928
2022-1026
2022-1140
2022-1232
2023-0116
2023-0214
2023-0312
2023-047
2023-071
2023-082
2023-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.